Priothera reveals positive mocravimod data
Therapy is well-tolerated in allogeneic haematopoietic cell transplantation (HCT) patients
Read More
Author: John Pinching
Stada and Xbrane gain EU approval for biosimilar Ximluci
Partnership combines Xbrane’s protein-expression system with Stada’s management teams
Read More
Bristol Myers Squibb opens 125-acre biologics campus in Dublin
Facility also includes a cell culture suite, quality control laboratories and technology labs
Read More
Brainomix and Visionable announce AI partnership
Link up will take on bottlenecks in time-sensitive stroke care pathway across the UK
Read More
EnteroBiotix announces partnership with Imperial College London
Collaboration includes a phase 2 clinical trial using microbiome therapeutics funded by the MRC
Read More- UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention
- Saphnelo approved in the US for subcutaneous self‑administration
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
